link to RWJMS home page

Welcome to The Cancer Institute of New Jersey

As one of the nation’s 40 National Cancer Institute-designated Comprehensive Cancer Centers and the only one in New Jersey, The Cancer Institute of New Jersey (CINJ) delivers advanced comprehensive care to adults and children, and conducts cutting-edge cancer research.  Our researchers and physicians transform discoveries into clinical practice and provide education and outreach regarding cancer prevention, detection and treatment. 

Through our Network of hospitals, the reach of CINJ is statewide providing the best cancer care and the most advanced treatment options through-out the state, quite literally bringing research to life across New Jersey, the nation and beyond.

NotepadRequest an Appointment                              

                  

You Tube Logo
facebook


Clinical Trials News

Study Examines Patterns in Post-Treatment Diet and Physical Activity for Colorectal Cancer Patients
In an effort to build the groundwork for future research on health promotion among individuals with colorectal and other cancers, a team of investigators at CINJ have launched a new study examining patterns in physical activity and eating habits of colorectal cancer patients who have recently finished treatment. The death rate from colorectal cancer has been on the decline for the past 15 years, which means more patients are surviving their disease. But are they surviving it in a way that enhances quality of life and minimizes the risk of cancer recurrence?  Read more about this colorectal cancer clinical trial.


Clinical Trial Looks to Harness Body’s Own Immune System to Tackle Pancreatic Cancer
It has been known for a number of years based on studies by scientists at CINJ and elsewhere, that the presence of a tumor in the body can actively inhibit the immune system from recognizing and destroying these same tumors. Studies at CINJ have shown this blockade of immunity also prevents traditional cancer vaccines from producing a good response.  As part of these studies at CINJ, investigators have shown that injecting a vaccine and other immunity-producing drugs into the tumor itself -- rather than the traditional site of the skin -- can result in a reversal of the immune blockade and the development of specific immunity to the tumor.  Learn more about this pancreatic cancer clinical trial.


Clinical Trial Focuses on New Immune Therapy in Combination with Standard Treatment for Common Form of Kidney Cancer             
Researchers at CINJ are evaluating whether the standard treatment for a common form of kidney cancer works better by itself or when combined with a certain type of blood cell that comes from a patient’s relative. The Sunitinib Plus Extended Courses of Irradiated Allogeneic Lymphocytes for Patients with Renal Cell Carcinoma -- or SPECIAL -- trial is sponsored by the United States Food and Drug Administration, which also will monitor the study.  Learn more about this kidney cancer clinical trial

 

Read "On the Cutting Edge: Patients in Clinical Trials of New Drugs Must Weigh Risk vs Reward" from the November issue of New Jersey Monthly magazine.

Find a Clinical Trial at CINJ

 

CINJ Network Portal Login

 

 

 

The Cancer Institute of New Jersey
A National Cancer Institute-designated
Comprehensive Cancer Center

 

195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ

 

 

 

 

The Information contained in this web site is not a substitute for medical consultation. A physician should always be consulted for any health problem or medical condition.